Lescol (fluvastatin sodium) capsules, Rx

Company: Novartis
Approval Status: Approved June 1999
Treatment for: Cardiology
Areas: Cardiovascular / Cardiology
Possible similar drugs: Lescol; Lescol XL

| General Information |

General Information

Lescol has been approved as a treatment for the reduction of triglycerides and ApoB in patients with primary hypercholesterolemia and mixed dyslipidemia.

< back to top

Lescol Drug Information

The Lescol drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.